In the present study, we evaluated the alterations in the expression of Nrf2 and Keap1 genes and Bcl-2, Bcl-XL and Bax genes as apoptotic pathway genes in various stages of the disease in patients with AML. The gene discussed is BCL2L1; the disease is acute myeloid leukemia.